BioACCESS research focuses on building analytical tools that can help promote more equitable access to essential biologic medicines, including recombinant proteins, monoclonal antibodies, and vaccines.
Economic Evaluation of Manufacturing Options for the Global Supply of Biologic Therapies: Location-Dependent Costs and Risks
BioACCESS is building computational tools that quantitatively evaluate the impact of manufacturing decisions, such as number and location of facilities within global manufacturing networks, on long-term financial and supply risks.
Modeling Manufacturing and Supply Logistics for Prospective SARS-CoV-2 Vaccines
This project is developing data-driven statistical models of strategic manufacturing and supply operations that will be essential for rapid and equitable global distribution of a SARS-CoV-2 vaccine.